Home » Topics » BioWorld Science

BioWorld Science
RSS

Bright Minds' BMB-101 for Dravet syndrome completes 28-day repeat toxicity studies

March 14, 2022

Del-1 potentiates BCI efficacy by blockade of tumor-infiltrating neutrophils

March 14, 2022

Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models

March 14, 2022

FDA grants orphan drug designation to HT-KIT for mastocytosis

March 14, 2022

Targeting PTP1B enhances T cell-mediated antitumor immunity

March 14, 2022

Study reveals dopamine as a sleep disorders target

March 14, 2022

RIG1 activation confers protection against SARS-CoV-2 infection in mice

March 14, 2022

Medshine Discovery identifies new cyclin/CDK inhibitors

March 14, 2022

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers

March 14, 2022

Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists

March 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...